484 Impact of 4-weekly capecitabine plus paclitaxel (XP) combination therapy for metastatic breast cancer: a multicenter phase II trial (KBCSG-0609)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(10)70505-x ◽

2010 ◽

Vol 8 (3) ◽

pp. 201

Author(s):

D. Yamamoto ◽

T. Taguchi ◽

N. Masuda ◽

T. Nakayama ◽

T. Nagata ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Combination Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Multicenter Phase

Download Full-text

Multicenter Phase II Trial of Weekly Paclitaxel for Advanced or Metastatic Breast Cancer: the Saitama Breast Cancer Clinical Study Group (SBCCSG-01)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyg075 ◽

2003 ◽

Vol 33 (8) ◽

pp. 371-376 ◽

Author(s):

K. Sato

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Clinical Study ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Weekly Paclitaxel ◽

Study Group ◽

Multicenter Phase ◽

Clinical Study Group

Download Full-text

Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial

Breast Cancer Research and Treatment ◽

10.1007/s10549-008-0306-9 ◽

2009 ◽

Vol 117 (3) ◽

pp. 591-598 ◽

Author(s):

Elmar Stickeler ◽

Maximilian Klar ◽

Dirk Watermann ◽

Annette Geibel ◽

Martha Földi ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Multicenter Phase ◽

Download Full-text

P5-19-06: Highly Effective of Gemcitabine and Cisplatin (GP) as First-Line Combination Therapy in Patients with Triple-Negative Metastatic Breast Cancer: Final Report of a Phase II Trial.

10.1158/0008-5472.sabcs11-p5-19-06 ◽

2011 ◽

Author(s):

Z Wang ◽

X Hu ◽

B Wang ◽

L Wang ◽

J Zhang ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Combination Therapy ◽

Phase Ii ◽

Triple Negative ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Final Report ◽

Gemcitabine And Cisplatin

Download Full-text

Capecitabine: The new standard in metastatic breast cancer failing anthracycline and taxane-containing chemotherapy? Mature results of a large multicenter phase II trial

European Journal of Cancer ◽

10.1016/s0959-8049(01)81191-6 ◽

2001 ◽

Vol 37 ◽

pp. S191 ◽

Author(s):

P. Reichardt ◽

G. von Minckwitz ◽

H.J. Lück ◽

P.C. Thuss-Patience ◽

W. Jonat ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Multicenter Phase

Download Full-text

Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-007-9591-y ◽

2007 ◽

Vol 108 (2) ◽

pp. 241-250 ◽

Author(s):

Keun Seok Lee ◽

Hyun Cheol Chung ◽

Seock Ah Im ◽

Yeon Hee Park ◽

Chul Soo Kim ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Polymeric Micelle ◽

Multicenter Phase

Download Full-text

Phase II trial of goserelin and exemestane combination therapy in premenopausal women with locally advanced or metastatic breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e11525 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e11525-e11525

Author(s):

Jiayu Wang ◽

Binghe Xu ◽

Peng Yuan ◽

Fei Ma ◽

Qing LI ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Combination Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Metastatic Breast ◽

Premenopausal Women

Download Full-text

Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy)

Investigational New Drugs ◽

10.1007/s10637-008-9166-8 ◽

2008 ◽

Vol 27 (2) ◽

pp. 166-172 ◽

Author(s):

G. Schilling ◽

M. Bruweleit ◽

N. Harbeck ◽

C. Thomssen ◽

K. Becker ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Combination Chemotherapy ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Efficacy And Safety ◽

Her2 Positive ◽

Multicenter Phase

Download Full-text

A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-012-1901-3 ◽

2012 ◽

Vol 70 (1) ◽

pp. 169-176 ◽

Author(s):

N. Karachaliou ◽

N. Ziras ◽

K. Syrigos ◽

K. Tryfonidis ◽

E. Papadimitraki ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Salvage Treatment ◽

Multicenter Phase ◽

Pretreated Patients

Download Full-text

Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-011-1570-7 ◽

2011 ◽

Vol 68 (4) ◽

pp. 1009-1016 ◽

Author(s):

R. Murialdo ◽

F. Bertolotti ◽

G. Pastorino ◽

M. Mencoboni ◽

M. Bergaglio ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Weekly Docetaxel ◽

Multicenter Phase ◽

Download Full-text

Abstract OT1-4-01: Multicenter phase II trial of the novel compound PM01183 (P) in BRCA1/2-associated or unselected metastatic breast cancer (MBC)

10.1158/0008-5472.sabcs13-ot1-4-01 ◽

2013 ◽

Author(s):

SJ Isakoff ◽

C Cruz ◽

J Garber ◽

A LLuch ◽

JA Perez Fidalgo ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

The Novel ◽

Multicenter Phase

Download Full-text